ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,231Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1290

$393K Total Retail Price of All Prescriptions

Rank: 262 out of 1290

544 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,274 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
BENAZEPRIL HCL 702 645 1 140
AMLODIPINE BESYLATE 696 651 2 3
CARVEDILOL 479 427 3 12
SIMVASTATIN 385 356 4 1
WARFARIN SODIUM 385 382 4 22
OMEPRAZOLE 282 257 6 2
LEVOTHYROXINE SODIUM 262 233 7 4
TORSEMIDE 251 216 8 296
BENAZEPRIL-HYDROCHLOROTHIAZIDE 231 213 9 343
CHLORTHALIDONE 213 211 10 274
BISOPROLOL-HYDROCHLOROTHIAZIDE 169 153 11 357
ATORVASTATIN CALCIUM 150 131 12 23
SERTRALINE HCL 148 134 13 36
HYDROCODONE-ACETAMINOPHEN 142 126 S3 14 6
METFORMIN HCL 129 91 15 10
ATENOLOL 121 100 16 18
CRESTOR 121 84 16 17
LOSARTAN POTASSIUM 118 108 18 19
DOXAZOSIN MESYLATE 117 110 19 64
BISOPROLOL FUMARATE 114 103 20 430
DIGOXIN 102 102 21 51
RANITIDINE HCL 102 97 21 49
METOPROLOL TARTRATE 98 89 23 7
TRAMADOL HCL 95 91 24 25
GLYBURIDE-METFORMIN HCL 92 92 R 25 147
LOVASTATIN 91 80 26 45
CLOPIDOGREL 86 68 27 24
LISINOPRIL 86 72 27 5
ALLOPURINOL 85 84 29 60
RAMIPRIL 81 74 30 136
MELOXICAM 79 78 31 31
CITALOPRAM HBR 77 77 32 29
TRAZODONE HCL 77 77 32 44
NEXIUM 76 58 34 34
GLIPIZIDE-METFORMIN 72 72 35 559
BUMETANIDE 72 70 35 196
PRAVASTATIN SODIUM 71 68 37 42
TAMSULOSIN HCL 68 52 38 11
DONEPEZIL HCL 67 65 39 13
GLIPIZIDE ER 67 58 39 206
FUROSEMIDE 65 60 41 9
HYDROCHLOROTHIAZIDE 65 57 41 20
ALENDRONATE SODIUM 63 63 43 39
DILTIAZEM ER 63 63 43 262
METOPROLOL SUCCINATE 63 61 43 14
PLAVIX 62 56 46 32
PANTOPRAZOLE SODIUM 61 50 47 48
NAMENDA 60 60 48 27
CEPHALEXIN 60 57 48 139
POTASSIUM CHLORIDE 55 55 50 35
DIOVAN 54 54 51 53
INSULIN SYRINGE 53 46 52 76
FENOFIBRATE 50 43 53 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.